- Targeting world-first regulatory approval and commercialization of BNCT, a new type of cancer treatments
- Driving innovative medical technology development by open innovation across manufacturing industries and domestic academia
Our Portfolio
STELLA PHARMA CORPORATION
| Outline | R&D, manufacturing and sales of medical products and medical devices |
|---|---|
| Website | |
| Industry | Health/medicine |
| Commercialization stage | Venture company |
Provided Support
| Authorized Investment | 3.5 billion yen (maximum) |
|---|---|
| Investment Structure |